Exosomes: A promising factor involved in cancer hypoxic microenvironments

Current Medicinal Chemistry

Volumn 22, Issue 36, 2015, Pages 4189-4195

  Yang, Y ^a   Yang, X ^a   Zhu, H ^a   Chen, X ^a   Zhang, H ^a   Wang, F ^b   Qin, Q ^a   Cheng, H ^a   Sun, X ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Biomarkers; Cancer; Cancer microenvironments; Exosomes; Hypoxia; Transmission signals

Indexed keywords

MICRORNA; NUCLEIC ACID; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER HYPOXIC MICROENVIRONMENT; CANCER PROGNOSIS; CANCER RESEARCH; CELL HYPOXIA; EXOSOME; FIBROBLAST; HUMAN; HYPOXIA; METASTASIS; NONHUMAN; PHENOTYPE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANOXIA; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; TUMOR INVASION;

ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; EXOSOMES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84955607102     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150825163318     Document Type: Article

References (32)

1. Jordan, B. F., Sonveaux, P. Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy. Front. Pharmacol., 2012, 3, 94.
2. Vaupel, P.; Mayer, A. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications. Adv. Exp. Med. Biol., 2014, 812, 19-24.
3. Mujcic, H.; Hill, R.P.; Koritzinsky, M.; Wouters, B.G. Hy-poxia signaling and the metastatic phenotype. Curr. Mol. Med., 2014, 14(5), 565-579.
4. Bensaad, K.; Harris, A. L. Hypoxia and metabolism in cancer. Adv. Exp. Med. Biol., 2014, 772, 1-39.
5. Yang, X.;, Zhu, H.; Ge, Y.; Liu, J.; Cai, J.; Qin, Q.; Zhan, L.; Zhang, C.; Xu, L.; Liu, Z.; Yang, Y.; Yang, Y.; Ma, J.; Cheng, H.; Sun, X. Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1alpha. Tumour Biol., 2014, 35(10), 10443-10448.
6. Hara, S.; Hamada, J.; Kobayashi, C.; Kondo, Y.; Imura, N. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem. Bio-phys. Res. Commun., 2001, 287(4), 808-813.
7. Huang, D.; Li, C.;. Zhang, H. Hypoxia and cancer cell metabolism. Acta Biochim. Biophys. Sin. (Shanghai), 2014, 46(3), 214-219.
8. Yun, Z.;Lin, Q. Hypoxia and regulation of cancer cell stemness. Adv. Exp. Med. Biol., 2014, 772, 41-53.
9. Warfel, N. A., El-Deiry, W. S. HIF-1 signaling in drug resistance to chemotherapy. Curr. Med. Chem., 2014, 21(26), 3021-3028.
10. Yang, X.; Zhang, C.; Zhu, H. C.; Qin, Q.;Zhao, L. J.; Liu, J.; Xu, L. P.; Zhang, Q.; Cai, J.; Ma, J. X.; Cheng, H. Y.; Sun, X. C. HIF-1alpha P582S and A588T polymorphisms and digestive system cancer risk-a meta-analysis. Tumour Biol., 2014, 35(3), 2825-2830.
11. Yang, X.; Zhu, H. C; Zhang, C.; Qin, Q.; Liu, J.; Xu, L. P.; Zhao, L. J.;Zhang, Q.; Cai, J.; Ma, X.; Cheng, H. Y.; Sun, X. C. HIF-1alpha 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies. PLoS One, 2013, 8(11), e80396.
12. Roma-Rodrigues, C.; Fernandes, A. R.; Baptista, P. V. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed. Res. Int., 2014, 2014, 179486.
13. EL Andaloussi, S.; Lakhal, S.; Mager, I.; Wood, M. J. A. Exosomes for targeted siRNA delivery across biological barriers. Adv. Drug Deliv. Rev., 2013, 65(3), 391-397.
14. Tickner, J. A.; Urquhart, A. J.; Stephenson, S. A.; Richard, D. J.; O'Byrne, K. J. Functions and therapeutic roles of exosomes in cancer. Front. Oncol., 2014, 4, 127.
15. Azmi, A.S.; Bao, B.; Sarkar, F.H. "Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review." Cancer Metastasis Rev., 2013, 32(3-4): 623-642.
16. Atay, S.; Godwin, A. K. Tumor-derived exosomes: A message delivery system for tumor progression. Commun. In-tegr. Biol., 2014, 7(1), e28231.
17. Simak, J.; Gelderman, M.P.; Yu, H.; Wright, V.; Baird, A.E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J. Thromb. Haemost., 2006, 4(6), 1296-1302.
18. Park, J.E.; Tan, H.S.; Datta, A.; Lai, R.C.; Zhang, H.; Meng, W.; Lim, S.K.; Sze, S.K. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and me-tastatic potential by secretion of proteins and exosomes. Mol. Cell Proteomics, 2010, 9(6), 1085-1099.
19. Inal, J. M.; Fairbrother, U.; Heugh, S. Microvesiculation and disease. Biochem. Soc. Trans., 2013, 41(1), 237-240.
20. Ye, J.; Wu, D.; Wu, P.; Chen, Z.; Huang, J. The cancer stem cell niche: cross talk between cancer stem cells and their mi-croenvironment. Tumour Biol., 2014, 35(5), 3945-3951.
21. King, H.W.; Michael, M.Z.; Gleadle, J.M. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 2012, 12, 421.
22. Tadokoro, H.; Umezu, T.; Ohyashiki, K.; Hirano T.; Ohya-shiki, J.H. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J. Biol. Chem., 2013, 288(48): 34343-34351.
23. Papi, A.; De Carolis, S.; Bertoni, S.; Storci, G.; Sceberras, V.; Santini, D.; Ceccarelli, C.; Taffurelli, M.; Orlandi M.; Bonafe, M. PPAR-γ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche. J. Cell Physiol., 2014, 229(11), 1595-1606.
24. Umezu, T.; Tadokoro, H.; Azuma, K.; Yoshizawa, S.; Ohyashiki, K.; Ohyashiki, J. H. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogene-sis by targeting factor-inhibiting HIF-1. Blood, 2014, 124(25), 3748-3757.
25. Kucharzewska, P.; Christianson, H.C.; Welch, J.E.; Svensson, K.J.; Fredlund, E.; Ringnér, M.; Mörgelin, M.; Bourseau-Guilmain, E.; Bengzon, J.; Belting, M. Exosomes reflect the hypoxic status of glioma cells and mediate hy-poxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA, 2013, 110(18), 7312-7317.
26. Gutwein, P.; Stoeck, A.; Riedle, S.; Gast, D.; Runz, S.; Condon, T. P.; Marme, A.; Phong, M. C.; Linderkamp, O.; Skorokhod, A.; Altevogt, P. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res., 2005, 11(7), 2492-2501.
27. Svensson, K. J.; Kucharzewska, P.; Christianson, H. C.; Skold, S.; Lofstedt, T.; Johansson, M. C.; Morgelin, M.; Bengzon, J.; Ruf, W.; Belting, M. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in en-dothelial cells. Proc. Natl. Acad. Sci. USA, 2011, 108(32), 13147-13152.
28. Ramteke, A.; Ting, H.; Agarwal, C.; Mateen, S.; Somasa-gara, R.; Hussain, A.; Graner, M.; Frederick, B.; Agarwal, R.; Deep, G. Exosomes secreted under hypoxia enhance in-vasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol. Carcinog., 2015, 54(7), 554-565.
29. Aga, M.; Bentz, G. L.; Raffa, S.; Torrisi, M. R.; Kondo, S.; Wakisaka, N.; Yoshizaki, T; Pagano, J.S.; Shackelford, J. Exosomal HIF1alpha supports invasive potential of naso-pharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene, 2014, 33(37), 4613-4622.
30. Wang, T.; Gilkes, D.M.; Takano, N.; Xiang, L.; Luo, W.; Bishop, C. J.; Chaturvedi, P.; Green, J.J.; Semenza, G. L. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc. Natl. Acad. Sci. USA, 2014, 111(31), E3234-E3242.
31. Vered, M.; Lehtonen, M.; Hotakainen, L.; Pirila, E.; Teppo, S.; Nyberg, P.; Sormunen, R.; Zlotogorski-Hurvitz, A.; Salo, T.; Dayan, D. Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study. BMC Cancer, 2015, 15, 25.
32. Thomas, S. N.; Liao, Z., Clark, D.; Chen, Y.; Samadani, R.; Mao, L.; Ann, D. K.; K; Baulch, J. E.; Shapiro, P.; Yang, A. J. Exosomal proteome profiling: a potential multi-marker cellular phenotyping tool to characterize hypoxia-induced radiation resistance in breast cancer. Proteomes, 2013, 1(2), 87-108.